Skip to main content
. 2020 Oct 23;10(11):1474. doi: 10.3390/biom10111474

Figure 3.

Figure 3

TP53/MDM2/CDKN2A alterations in biliary tract cancers (BTCs). (A) Frequency of TP53/MDM2/CDKN2A alterations in different studies. (B) The association between TP53/MDM2/CDKN2A alterations. Data were accessed at cBioPortal on 3 September 2020.